Programmed Death Ligand 1 (PDL1) Expression in Neoadjuvant Triple‐Negative Breast Cancer: Association With Chemotherapy Response and Residual Cancer Burden

The Breast Journal · Published 2025-01-01 · DOI 10.1155/tbj/8856567

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1155/tbj/8856567

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year
2025

Related articles